Eisai
4523.T
#1531
Rank
NZ$18.47 B
Marketcap
$65.28
Share price
-0.05%
Change (1 day)
-35.33%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Market capitalization of Eisai (4523.T)

Market cap: NZ$18.47 Billion

As of September 2024 Eisai has a market cap of NZ$18.47 Billion. This makes Eisai the world's 1531th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eisai from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$18.47 B-18.54%
2023NZ$22.67 B-22.86%
2022NZ$29.40 B23.75%
2021NZ$23.75 B-16.59%
2020NZ$28.48 B-10.98%
2019NZ$32.00 B-2.65%
2018NZ$32.87 B43.56%
2017NZ$22.89 B-3.86%
2016NZ$23.81 B-14.84%
2015NZ$27.96 B96.64%
2014NZ$14.22 B5.5%
2013NZ$13.48 B-7.4%
2012NZ$14.55 B-2.78%
2011NZ$14.97 B11.92%
2010NZ$13.38 B-8.01%
2009NZ$14.54 B-30.68%
2008NZ$20.98 B38.72%
2007NZ$15.12 B-32.19%
2006NZ$22.30 B27.15%
2005NZ$17.54 B32.31%
2004NZ$13.25 B8%
2003NZ$12.27 B-1.91%
2002NZ$12.51 B-29.2%
2001NZ$17.67 B-24.44%
2000NZ$23.39 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Eisai was reported to be:

NZ$18.47 Billion
by Yahoo Finance info icon info icon
NZ$18.47 Billion
by CompaniesMarketCap info icon info icon